QuantaMatrix
퀀타매트릭스 · 317690
Health Care Medical Devices · KOSDAQ
Market cap US$44.9M (₩61.9B)
Overview
QuantaMatrix makes in-vitro diagnostic (IVD) devices, instruments that test blood, urine, and other bodily fluids outside the body to detect disease, guide treatment, and predict patient outcomes.
Its products are supplied to large hospitals and independent clinical-testing laboratories in Korea and internationally. Listed on KOSDAQ, Korea's tech-focused small-cap exchange, the company focuses primarily on microbiology diagnostics, particularly devices that test for sepsis and bloodstream infections and determine which antibiotics will work against the bacteria found.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$2.3M
- FY2024US$1.8M
- FY2025US$2.7M
Operating profit
- FY2023−US$16.3M
- FY2024−US$11.7M
- FY2025−US$11.3M
Net income
- FY2023−US$15.6M
- FY2024−US$14.6M
- FY2025−US$14.1M
Key ratios (FY2025)
Price charts coming soon
Interactive price history isn't here yet. Would you use it?